CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy.
Rodriguez-Garcia A, Lynn RC, Poussin M, Eiva MA, Shaw LC, O'Connor RS, Minutolo NG, Casado-Medrano V, Lopez G, Matsuyama T, Powell DJ. · 2021
Read CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy. by Rodriguez-Garcia A, Lynn RC, Poussin M, Eiva MA, Shaw LC, O'Connor RS, Minutolo NG, Casado-Medrano V, Lopez G, Matsuyama T, Powell DJ. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7873057.txt.
Description
Rodriguez-Garcia and co-authors use CAR T cells to clear suppressive macrophages from tumors. The tumor setting blocks immunotherapy for many patients. Tumor macrophages are a major part of that block. Some push tumors forward, and others fight them.
A macrophage subset wearing folate receptor β acts suppressive. The team built CAR T cells to kill just that subset. In mouse tumors, clearing them changed the scene. Fresh inflammatory cells moved in. The body's own tumor-specific killer T cells followed. Tumors grew slower and mice lived longer. Pre-clearing also boosted a second CAR T therapy. Giving both at once did not help, though.
Catalog record
| CREATOR | Rodriguez-Garcia A, Lynn RC, Poussin M, Eiva MA, Shaw LC, O'Connor RS, Minutolo NG, Casado-Medrano V, Lopez G, Matsuyama T, Powell DJ. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 102 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |